Soluble interleukin 6 receptor levels are associated with reduced myocardial reperfusion after percutaneous coronary intervention for acute myocardial infarction

Cytokine
Hilde E GrootPim van der Harst

Abstract

Interleukin-6 receptor (IL-6R) signalling has been suggested to play a causal role in the development and outcome of coronary heart disease (CHD). The aim of this study was to investigate the association of sIL-6R levels with myocardial reperfusion after percutaneous coronary intervention (PCI) for acute ST-elevated myocardial infarction (STEMI). Blood was sampled from 70 patients presenting with STEMI at 6 different time-points (baseline, post-PCI, t=1h, t=6h, t=24h, t=2w). Coronary angiograms post-PCI were analysed for myocardial blush grade (MBG) as indicator of myocardial reperfusion. Serum IL-6 and sIL-6R were measured using IL-6 and sIL-6R enzyme-linked immunosorbent assays (ELISA). sIL-6R levels fluctuated biphasic during the two weeks after STEMI. Reduced MBG was associated with a larger change in sIL-6R levels between baseline and post-PCI compared to optimal MBG (-13.40; SEM 2.78ng/ml vs -1.99; SEM 2.35ng/ml, respectively; p<0.001). Patients with reduced MBG also showed a larger increase in sIL-6R levels after PCI and 1h after myocardial infarction (MI) compared to optimal MBG (respectively 11.56; SEM 2.68ng/ml vs 3.02; SEM 2.39ng/ml; p=0.018). IL-6/sIL-6R ratio was also more increased in patients with reduced MBG at ...Continue Reading

References

Dec 18, 2001·Cardiovascular Research·Nikolaos G FrangogiannisMark L Entman
Jun 26, 2004·Circulation Research·Min NianPeter Liu
Feb 21, 2006·Mediators of Inflammation·Fien BlanckeChris J Vrints
Aug 29, 2007·Immunology and Cell Biology·Heike Knüpfer, Rainer Preiss
May 21, 2010·Circulation. Cardiovascular Interventions·Murat SezerSabahattin Umman
Jan 29, 2011·Clinical Science·Haidong ZhuPim van der Harst
Feb 8, 2011·Biochimica Et Biophysica Acta·Jürgen SchellerStefan Rose-John
Nov 9, 2011·Nature Medicine·Christian Weber, Heidi Noels
Mar 17, 2012·Lancet·UNKNOWN IL6R Genetics Consortium Emerging Risk Factors CollaborationJohn Danesh
Mar 17, 2012·Lancet·UNKNOWN Interleukin-6 Receptor Mendelian Randomisation Analysis (IL6R MR) ConsortiumJuan Pablo Casas
Jun 23, 2012·Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance·Declan P O'ReganStuart A Cook
Jul 31, 2012·Lancet·Jürgen Scheller, Stefan Rose-John
Nov 9, 2012·International Journal of Biological Sciences·Stefan Rose-John
Apr 2, 2014·JAMA : the Journal of the American Medical Association·Chris P H LexisUNKNOWN GIPS-III Investigators

❮ Previous
Next ❯

Citations

Jul 28, 2018·Cardiovascular Research·Louise ZieglerBruna Gigante
Jul 15, 2016·Journal of the American Heart Association·Vibeke N RitschelGeir Ø Andersen
Feb 25, 2017·The International Journal of Cardiovascular Imaging·Lei ZhaoYuhai Yang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.